Monocytes and macrophages are myeloid cells that have important innate immune functions. Macrophages reside in tissues and respond to infection by producing inflammatory mediators and engulfing ...

A hematologist oncologist is a doctor who specializes in treating cancers of the blood. They have extra training in the blood system, lymphatic system, bone marrow, and cancers. The term “hemato ...

Chronic myelogenous leukemia (CML) is characterized by a reciprocal translocation between chromosomes 9 and 22 that produces the Philadelphia chromosome. CML is characterized by marked ...

Acute myeloid leukemia (AML) is a cancer of immature blood cells. When the early myeloid cell matures normally, it will become either a mature white blood cell, red blood cell, or platelet. But ...

Acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) are blood cell cancers that start in the bone marrow. AML is more common and more aggressive than CML. AML is usually treated with ...

The 2022 WHO diagnostic guidelines include a supportive criterion that uses flow cytometry analysis of monocyte populations. 1 Human monocytes can be characterized into 3 groups based on the ...

The 5-year relative survival rate for AML is 31.9%. Chronic myeloid leukemia (CML) affects mostly adults. About 9,000 new cases of CML are diagnosed annually, according to the NCI. The 5-year ...

Chronic fatigue syndrome — also known as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) OR systemic exertional intolerance disease (SEID)— is a serious, chronic illness that can ...

The five stages of chronic kidney disease (CKD) indicate how well the kidneys are working, ranging from stage 1 (mild kidney damage) to stage 5 (kidney failure). The staging of CKD is based on a blood ...

Chronic Myeloid Leukemia (CML) treatment has come a long way, with targeted therapies like tyrosine kinase inhibitors (TKIs) helping many patients live full, healthy lives. But while these medications ...

CML is a cancer of the blood and bone marrow. According to the National Institutes of Health, an estimated 5,430 people will be diagnosed with CML in 2012. Synribo is intended to be used in ...

In this application note, explore how scientists can couple a serum-free medium with a xeno-free serum replacement to effectively culture functional monocyte-derived dendritic cells and macrophages.